BACKGROUND: Prognostication is a core component of palliative care consultation. We sought to incorporate predicted survival into the routine practice of our hospital-based palliative care team. METHODS: The predicted survival was determined by the physician and/or nurse at the time of initial palliative care consultation using categories that parallel the rough time frames often shared with patients and used in planning care: (1) ≤3 days, (2) 4 days to 1 month, (3) >1 month to 6 months, (4) >6 months. One year later, survival status at 6 months was determined using death certificates, the Social Security online database, and other methods. RESULTS: Over 1 year, complete data were obtained for 429 of 450 (95.3%) consecutive new patient consults. Patients' mean and median age was 63, 48.5% had cancer, 83% were Caucasian, and 50% were female. For the 283 patients who were discharged alive, median survival was 18 days and 58 patients were still alive after 6 months. Fifty-eight percent of patients were assigned to the correct survival category, whereas 27% of prognoses were too optimistic and 16% were too pessimistic. In logistic regression analysis, predicted survivals of ≤3 days were much more likely to be accurate than longer predictions. DISCUSSION: The team recorded a predicted survival in 95% of new patient consults. Fifty-eight percent accuracy is in line with prior literature. Routinely incorporating survival prediction into palliative care consultation raised a number of questions. What decisions were made based on the 42% incorrect prognoses? Did these decisions negatively affect care? Survival prediction accuracy has potential as a quality measure for hospital-based palliative care programs, however to be truly useful it needs to be shown to be "improveable" and the downstream effects of predictions need to be better understood.
BACKGROUND: Prognostication is a core component of palliative care consultation. We sought to incorporate predicted survival into the routine practice of our hospital-based palliative care team. METHODS: The predicted survival was determined by the physician and/or nurse at the time of initial palliative care consultation using categories that parallel the rough time frames often shared with patients and used in planning care: (1) ≤3 days, (2) 4 days to 1 month, (3) >1 month to 6 months, (4) >6 months. One year later, survival status at 6 months was determined using death certificates, the Social Security online database, and other methods. RESULTS: Over 1 year, complete data were obtained for 429 of 450 (95.3%) consecutive new patient consults. Patients' mean and median age was 63, 48.5% had cancer, 83% were Caucasian, and 50% were female. For the 283 patients who were discharged alive, median survival was 18 days and 58 patients were still alive after 6 months. Fifty-eight percent of patients were assigned to the correct survival category, whereas 27% of prognoses were too optimistic and 16% were too pessimistic. In logistic regression analysis, predicted survivals of ≤3 days were much more likely to be accurate than longer predictions. DISCUSSION: The team recorded a predicted survival in 95% of new patient consults. Fifty-eight percent accuracy is in line with prior literature. Routinely incorporating survival prediction into palliative care consultation raised a number of questions. What decisions were made based on the 42% incorrect prognoses? Did these decisions negatively affect care? Survival prediction accuracy has potential as a quality measure for hospital-based palliative care programs, however to be truly useful it needs to be shown to be "improveable" and the downstream effects of predictions need to be better understood.
Authors: Francis Lau; Denise Cloutier-Fisher; Craig Kuziemsky; Fraser Black; Michael Downing; Elizabeth Borycki; Francis Ho Journal: J Palliat Care Date: 2007 Impact factor: 2.250
Authors: Francis Lau; Vincent Maida; Michael Downing; Mary Lesperance; Nicholas Karlson; Craig Kuziemsky Journal: J Pain Symptom Manage Date: 2009-02-20 Impact factor: 3.612
Authors: Erik K Fromme; Paul B Bascom; M D Smith; Susan W Tolle; Lissi Hanson; David H Hickam; Molly L Osborne Journal: J Palliat Med Date: 2006-08 Impact factor: 2.947
Authors: Oludamilola Olajide; Laura Hanson; Barbara M Usher; Bahjat F Qaqish; Robert Schwartz; Stephen Bernard Journal: J Palliat Med Date: 2007-02 Impact factor: 2.947
Authors: J C Weeks; E F Cook; S J O'Day; L M Peterson; N Wenger; D Reding; F E Harrell; P Kussin; N V Dawson; A F Connors; J Lynn; R S Phillips Journal: JAMA Date: 1998-06-03 Impact factor: 56.272
Authors: David J Casarett; Sue Farrington; Teresa Craig; Julie Slattery; Joan Harrold; Betty Oldanie; Jason Roy; Richard Biehl; Joan Teno Journal: J Palliat Med Date: 2012-05-14 Impact factor: 2.947
Authors: Sara Mandelli; Emma Riva; Mauro Tettamanti; Ugo Lucca; Davide Lombardi; Gianmaria Miolo; Simon Spazzapan; Rita Marson Journal: Support Care Cancer Date: 2020-08-31 Impact factor: 3.603
Authors: Jon P Furuno; Brie N Noble; Kristi N Horne; Jessina C McGregor; Miriam R Elman; David T Bearden; Eric W Walsh; Erik K Fromme Journal: Antimicrob Agents Chemother Date: 2014-07-07 Impact factor: 5.191
Authors: Roberto Forero; Geoff McDonnell; Blanca Gallego; Sally McCarthy; Mohammed Mohsin; Chris Shanley; Frank Formby; Ken Hillman Journal: Emerg Med Int Date: 2012-03-06 Impact factor: 1.112